IBRX vs RXRX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

IBRX

39.5
AI Score
VS
RXRX Wins

RXRX

44.1
AI Score

Investment Advisor Scores

IBRX

40score
Recommendation
SELL

RXRX

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBRX RXRX Winner
Revenue 95.45M 14.14M IBRX
Net Income -863.16M -248.51M RXRX
Net Margin -904.3% -1757.1% IBRX
Operating Income -131.49M -263.47M IBRX
ROE 82.5% -27.2% IBRX
ROA -137.3% -20.5% RXRX
Total Assets 628.50M 1.21B RXRX
Cash 75.67M 545.68M RXRX
Current Ratio 5.72 5.03 IBRX
Free Cash Flow -147.15M -187.35M IBRX

Relative Price Performance (Last 90 Days)

IBRX 1M: +2.2% · 3M: +9.9% RXRX 1M: -2.7% · 3M: +1.6%

Current Technical Phase

IBRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.3% over 20 days), RSI 50

RSI (14): 50.4 · Price: $7.91

RXRX

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope 0.1%) with fading momentum, RSI 46

RSI (14): 45.6 · Price: $3.20

Fundamentals Snapshot

Metric IBRX RXRX
Market Cap
Forward P/E -62.4 -3.6
Trailing P/E
Revenue (TTM)
Revenue Growth 0.9% -0.6%
Gross Margin 1.0% -7.2%
Operating Margin -1.2% -17.6%
EPS -0.91 -0.98
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, RXRX is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.